A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression

Overview of attention for article published in Molecular Cancer, July 2011

Altmetric Badge

Mentioned by

f1000: 1 research highlight platform

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 18 Mendeley

Summary Research highlights Dimensions citations

So far, Altmetric has seen 1 review on a research highlight platform.

Recommended in Faculty Opinions

21 Oct 2011

This research output was recommended by a member of Faculty Opinions.